加利福尼亚大学旧金山分校教授
Dr. Daniel E. Johnson is a biochemist and leading researcher in the fields of otolaryngology and cancer biology. Dr. Johnson’s research is focused on identifying cellular signaling pathways that contribute to cancer and the acquisition of drug resistance. Using the knowledge he derives from his studies, he develops new therapeutic agents and strategies for the prevention and treatment of cancer. Dr. Johnson places important emphasis on translating findings from his laboratory to the clinic and has facilitated the development of clinical trials in both leukemia and head and neck cancer. While a professor at the University of Pittsburgh (1993-2016), Dr. Johnson served as Scientific Director of the Acute Leukemia Working Group. Since 2016, he has been on faculty at the University of California San Francisco, where he serves as Vice Chair for Research in the Department of Otolaryngology – Head and Neck Surgery. He has published over 140 papers, served as Section Editor for the journal Leukemia, is Editor of two books, and has maintained continuous NIH funding for his research since 1995. He has served on multiple NIH and American Cancer Society Study Sections and on the Board of Scientific Counselors for the National Institute on Deafness and Communication Disorders.